Neuronostics: Funding, Investors & Team (Sep 2026)
Neuronostics Ltd is a newly established University of Exeter (UK) spin-out, focussed on the development and commercialisation of a novel and potentially revolutionary seizure susceptibility assessment technology called #BioEP.
Neuronostics has raised $900k across 1 funding round on record, the most recent an undisclosed round of $900k announced in Sep 2020.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Neuronostics Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Neuronostics Funding Rounds
Neuronostics Founders and Leadership Team
No contact details are on record for this team yet.
Neuronostics Funding Compared to Other Health Care Startups
Neuronostics' latest round of $900k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neuronostics in Health Care and Exeter
Companies Similar to Neuronostics
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Asterix Health is the workforce solution for modern healthcare.
Gloucester Rugby is a professional English rugby union club that gives up to date with all the information…
Neuronostics Funding FAQs
What does Neuronostics do?
Neuronostics Ltd is a newly established University of Exeter (UK) spin-out, focussed on the development and commercialisation of a novel and potentially revolutionary seizure susceptibility assessment technology called #BioEP.
How much funding has Neuronostics raised?
Neuronostics has raised $900k across 1 round on record. The most recent is an undisclosed round of $900k announced in Sep 2020.
When did Neuronostics last raise funding?
Neuronostics' most recent funding round on record is an undisclosed round of $900k, announced in Sep 2020.
Who is the CEO of Neuronostics?
John Terry is listed as CEO at Neuronostics.
Where is Neuronostics headquartered?
Neuronostics is based in Exeter, Devon, United Kingdom.
How many employees does Neuronostics have?
Neuronostics is in the 1-10 employee band.
How does Neuronostics' funding compare to other Health Care startups?
Neuronostics' latest round of $900k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Neuronostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neuronostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.